// App-Quantinova.ai

TCTAP A-046 : Everolimus- Versus Zotarolimus-Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions (From an IRIS-MAIN Registry Substudy)

Researchers

Presenter

  • Yu Na Kim

Principal Investigators

  • Seung-Jung Park

  • Seong-Wook Park

  • Cheol Hyun Lee

  • Cheol Whan Lee

  • Young-Hak Kim

  • Seung-Whan Lee

  • Duk-Woo Park

  • Soo-Jin Kang

  • Jung-Min Ahn

  • Pil Hyung Lee

  • Se Hun Kang

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary artery lesions

  • Myocardial infarction

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved